News

Delayed response predicts need for extended antibiotics for inpatients with low-risk, gram-negative bacteremias


 

FROM INFECTIOUS DISEASES IN CLINICAL PRACTICE

References

Antibiotic therapy for 7 days or less may be just as effective as longer courses of antibiotics for select inpatients with uncomplicated gram-negative bacteremia from urinary infections, based on a retrospective, single-center analysis by researchers at Maimonides Medical Center in New York.

Hospitalized patients whose temperatures returned to levels below 100.4º F within 72 hours of starting therapy appeared to do well on short-course (7 days or less) antibiotic therapy, Siddharth Swamy, Pharm.D., and his colleagues reported in a study in Infectious Diseases in Clinical Practice posted online Dec. 30, 2015. However, increased clinical failures were noted in patients with a delayed response to therapy, indicating that duration of therapy needs to be individualized for each patient.

The researchers reviewed 178 eligible cases of gram-negative bacteremia. The most common source of bacteremia was the urinary tract (53%), followed by catheters (14%), and unknown sources (14%).

Patients were treated with antibiotics for either 7 days or less (42 patients), 8-14 days (100 patients), or more than 14 days (36 patients). The patients in the study were comparable, with the exception of a higher percentage of patients in the short-course antibiotic group who no longer had temperatures above 100.4º F within 72 hours of initiating therapy. The respective percentage of patients who had defervesced in 72 hours or less was 79% for 7 days or less of therapy, 69% for 8-14 days of therapy, and 36% for more than 14 days of therapy (P = .0002). Overall clinical response rates were 79% for 7 days or less of antibiotics, 89% for 8-14 days of therapy, and 81% for more than 14 days of therapy. Microbiologic cure rates were 83%, 89, and 92%, respectively; the differences were nonsignificant.

However, persisting fever predicted clinical response: Among patients who defervesced after 72 hours, the short-course treatment group had a significantly decreased clinical response rate, compared with intermediate- and long-course treatment groups (11%, 65%, 70%, respectively; P = .03).

The most common infectious pathogens were Escherichia coli (46%) and Klebsiella pneumoniae (22%); most cases were low-inocula bacteremias and were related to urinary tract infections in 53% of the cases. Thus, the findings “are not necessarily applicable to high-inocula bacteremias, nonlactose-fermenting gram-negative organisms, or multidrug-resistant gram-negative organisms,” the researchers wrote.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

Hepatitis C virus infection linked to cardiovascular death, disease, and stroke
MDedge Family Medicine
White House launches new plan to combat multidrug-resistant TB
MDedge Family Medicine
Testing, early antiretroviral treatment could slash HIV infection rate in men
MDedge Family Medicine
Oral fluconazole raises miscarriage risk
MDedge Family Medicine
Novel treatments assessed in midst of Ebola crisis
MDedge Family Medicine
Hospital-acquired pneumonia threatens cervical spinal cord injury patients
MDedge Family Medicine
LAIV, IIV almost equally effective against influenza
MDedge Family Medicine
Novel polio vaccine strains promise improved post-eradication safety
MDedge Family Medicine
Infectious disease in elderly a significant burden for EDs
MDedge Family Medicine
Consider reimmunizing with MMR after HIV-infected children undergo antiretroviral treatment
MDedge Family Medicine